Insurance Stopped Covering Your GLP-1? What to Do

You opened a letter, a benefits-portal notice, or an email from HR, and the message was the same: your plan will no longer cover your weight loss medication for weight management. You are already on it. It is working. And now you are doing the math on what happens when your current supply runs out. That is a stressful place to be, and you are not the only one there right now. A number of employers and insurers have narrowed or ended GLP-1 coverage for weight management, largely because of cost. It is about your plan’s budget, not your progress.

This page is for you if you had coverage and lost it. If you were never approved in the first place, start here instead: Insurance Denied Your GLP-1. If your coverage was dropped mid-treatment, keep reading. Here is why this is happening, how to confirm exactly what changed on your plan, and three even-handed options to keep going.

Transformation Health is an independent guide, not a provider: we do not prescribe, sell medication, or work with insurance. This content is for general education and is not medical advice. Talk with a licensed provider about your situation.

Why coverage is being dropped right now

The short version is cost. GLP-1 medications are expensive, and when an employer or insurer announces it is scaling back coverage for weight management, cost is usually the reason it gives.

Insurers have made these moves too, not only employers. Blue Cross Blue Shield of Massachusetts, for example, told providers in a May 29, 2025 notice that starting January 1, 2026, and as plans renew through 2026, its affected formularies would stop covering GLP-1 medications for weight loss and cover them only for type 2 diabetes. The notice said exceptions and appeals would not be available, and that coverage would continue only where an employer buys a rider to keep it.^[1]

The medication did not stop working for you. This is a business response to a category that got expensive fast, not a verdict on whether you should be on it. That tells you where to focus: on finding the path that fits how your coverage actually changed.

First, confirm exactly what changed

Before you choose an option, read your notice carefully. Three details determine what makes sense for you.

What exactly was dropped. Many plans that stop covering GLP-1s for weight management continue to cover GLP-1 medications when they are prescribed for type 2 diabetes. If you have a qualifying diagnosis, coverage may still be available under a different indication. This is the single most important thing to check first, because it can reshape your next step.

The effective date. Find the date your current coverage actually ends. Sometimes the change takes effect at a plan-year boundary, such as January 1, and sometimes it follows your group’s renewal date. Knowing the exact date tells you how much time you have to sort out your next move and whether you can avoid a gap in your medication.

Who made the change. An employer that chose to opt out of weight management coverage is a different situation from an insurer changing the underlying plan. If your employer sponsors the plan, your HR or benefits team can tell you whether the decision was theirs and whether other options exist, such as a different plan at open enrollment. If the insurer changed the plan, your member services line is the place to ask.

Once you know what changed, when it takes effect, and who drove it, the right option gets much clearer. You can also review the broader picture of insurance coverage for weight loss medication if you want context on how different plan types tend to handle GLP-1s.

Your three options, side by side

There is no single right answer here. The right path depends on what your notice said and what matters most to you: keeping coverage if you can, minimizing cost, or avoiding a gap in your medication. Here is an honest look at all three.

Appeal or request an exception through your plan

You can ask your plan about the change and, in many cases, file an appeal or request a coverage exception. HealthCare.gov explains that you can ask your insurer for an internal appeal and, in many cases, take it to an independent external review.^[2] Set your expectations honestly, though. An appeal is unlikely to overturn a categorical benefit removal, which is a plan-wide decision to stop covering an entire category of medication. That is different from an individual medical-necessity denial, where the plan turned down one person’s request and stronger documentation can sometimes reverse it. If your plan kept coverage for type 2 diabetes and you have that diagnosis, asking whether the medication can be covered under that indication is often the more productive route.

If your employer offers more than one plan, check at your next open enrollment whether another option still covers GLP-1 medications for weight management, and compare its formulary and prior authorization rules before you switch.

If you do want to pursue an appeal, you do not need to relearn the whole process here. Our guide on GLP-1 prior authorization walks through how the appeal process actually works, and the denied-by-insurance page covers reading and strengthening a determination step by step.

Manufacturer patient assistance programs

If you want to stay on a brand-name medication, the manufacturers offer a few kinds of help, and they work differently.

Savings cards lower the copay for people whose commercial insurance covers the drug. As of 2026-10-16, the Wegovy savings offer is for patients with commercial insurance and excludes government beneficiaries, and the Zepbound savings card requires a commercial drug plan and excludes people enrolled in government-funded programs such as Medicare, Medicaid, or VA coverage.^[3][4] Check the current terms to see whether a card applies when your plan no longer covers the drug for weight management.

Self-pay options do not use insurance. As of 2026-10-16, Wegovy self-pay prescriptions are filled through NovoCare Pharmacy, with a price that varies by dose, and Lilly lists a Zepbound KwikPen self-pay offer through LillyDirect Pharmacy or another pharmacy; Lilly notes that self-pay costs cannot be submitted to insurance or applied to a deductible.^[3][4] Check each manufacturer’s current page for prices.

Patient assistance programs, often shortened to PAPs, are a separate type of help that can lower or cover the cost for people who meet their criteria. Many are designed for people with little or no prescription drug coverage and have income limits, so not everyone qualifies. NeedyMeds keeps a searchable database of these programs.^[5] Our page on manufacturer patient assistance programs covers who tends to qualify and how to apply, and GLP-1 savings programs compares the options in more detail.

Cash-pay compounded telehealth

The third option does not use insurance at all. Cash-pay telehealth programs charge you directly, so there is no prior authorization and no formulary to check. Some prescribe brand-name medications and some prescribe compounded medications.

Compounded semaglutide or tirzepatide is prepared by a compounding pharmacy. Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality, and they are not the same as brand-name products such as Wegovy or Zepbound. They may differ in formulation, purity, and potency.^[6] It is a separate path, not a swap for what your plan used to cover, and whether it is appropriate for you is a decision for a licensed provider. Our page on compounded GLP-1 without insurance explains the details.

Program options to review

Cash-pay programs differ in what they charge for and what they include. Before you sign up for any program, compare the total cost: medication, dose increases, visits, labs, shipping, membership fees, and cancellation terms. Read the program’s terms for what the monthly fee covers, what is billed separately, and how cancellation works. Prices vary by program and dose, so confirm the current price with the program before you pay.

Ask whether the program prescribes brand-name or compounded medication, and if compounded, which pharmacy prepares it. If you want to compare cash-pay programs against paying out of pocket at a pharmacy, our overview of your options for paying without insurance breaks down how the numbers tend to work.

Transformation Health does not accept payment from providers. How we make money.

How the process should work

Because there is no insurance involved, the process is usually simpler than the appeal route.

At most cash-pay telehealth programs, you complete an online intake form covering your health history, a licensed provider reviews it and decides whether a prescription is appropriate, and if it is, the prescription goes to a pharmacy. Some states require a live video visit before certain prescriptions can be written; a program should tell you if that applies where you live.

If you are switching from a medication your plan used to cover, tell the new prescriber what you have been taking and at what dose. Dose decisions are the prescriber’s call.

For more on this route, see our overview of getting a GLP-1 without insurance.

Frequently Asked Questions

Why did my insurance stop covering my weight loss medication?

In most announcements, the stated reason is cost. GLP-1 medications are expensive, and some employers and insurers have responded by narrowing or ending coverage for weight management while keeping coverage for type 2 diabetes. It is a decision about the plan’s benefits, not about you personally.

My employer dropped GLP-1 coverage. Can I appeal?

You can always ask your plan about the change and, in many cases, file an appeal or request an exception. Be realistic, though. A plan-wide decision to stop covering a category of medication is different from an individual medical-necessity denial, and some plans state that a benefit exclusion cannot be appealed. Check your notice for the effective date and any appeal deadline, then contact your plan’s member services line to understand your specific rights.

Is my medication still covered if I have type 2 diabetes?

Often, yes. Many plans that drop GLP-1 coverage for weight management keep covering GLP-1 medications prescribed for type 2 diabetes. Blue Cross Blue Shield of Massachusetts, for example, said in a May 29, 2025 provider notice that starting with plan renewals on or after January 1, 2026, GLP-1 medications on its affected formularies would be covered only for type 2 diabetes, with prior authorization.^[1] Read your notice closely to see which indication changed, because that single detail shapes your options.

What can I do before my current coverage runs out?

Start by confirming the effective date on your notice so you know exactly when coverage ends. From there you can ask your plan about an exception, compare plans at your next open enrollment, check the manufacturer’s savings and self-pay options, or compare cash-pay telehealth programs. At most telehealth programs, a licensed provider decides whether a prescription is appropriate. Talk with your prescriber early so there is time to plan.

How much does a cash-pay GLP-1 program cost without insurance?

Prices vary by program, medication, and dose. Compare the total cost, not just the first month: medication, dose increases, visits, labs, shipping, membership fees, and cancellation terms. Read what the monthly fee covers and what is billed separately. Some programs prescribe compounded medications, which are not FDA-approved; the FDA does not review them for safety, effectiveness, or quality, and they are not the same as brand-name products.

Next steps

If your coverage was dropped, start with your notice: what changed, when, and who made the change. Then check the options that fit, in whatever order makes sense for you: your plan’s exception or appeal process, your next open enrollment, the manufacturer’s savings and self-pay options, or cash-pay programs. There is no rush and no pressure. If you want to understand how cash-pay telehealth works before choosing, you can see how the online prescription process works.

Sources

[1] Blue Cross Blue Shield of Massachusetts, “GLP-1 medications for obesity: coverage update” (provider news), May 29, 2025. Accessed 2026-10-16. https://provider.bluecrossma.com/ProviderHome/portal/home/news/news/clinical-and-pharmacy/all%20networks/glp-1%20medications%20for%20obesity%20-%20coverage%20update

[2] HealthCare.gov (Centers for Medicare and Medicaid Services), “How to appeal an insurance company decision.” Accessed 2026-10-16. https://www.healthcare.gov/appeal-insurance-company-decision/

[3] Novo Nordisk. “Save on Wegovy” (coverage and savings). Accessed 2026-10-16. https://www.wegovy.com/coverage-and-savings/save-on-wegovy.html

[4] Eli Lilly and Company. “Zepbound Coverage and Savings.” Accessed 2026-10-16. https://zepbound.lilly.com/coverage-savings

[5] NeedyMeds. “Patient Assistance Programs Database.” Accessed 2026-10-16. https://www.needymeds.org/

[6] U.S. Food and Drug Administration, “Compounding and the FDA: Questions and Answers.” https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers

Important disclosures

The information on this page about coverage changes, appeals, and manufacturer programs is general and educational. It does not represent the terms of your specific plan and is not legal advice. Coverage rules, effective dates, and appeal procedures vary by insurer, employer, and state. For details on your own situation, contact your plan’s member services line, your employer’s benefits team, and your prescribing provider’s office.